How to Verify the Quality and Purity of Pharmaceutical Raw Materials: Key Steps for Drug Manufacturers

Photo: Patrick Hendry / Unsplash

Drug manufacturing places extreme demands on raw materials—both in terms of purity and consistency and stability. Even a minor deviation in quality can compromise the efficacy of the final product or lead to costly production errors. For manufacturers, it is therefore crucial not only to select the right supplier but also to systematically verify each batch of raw materials before use. This process includes analyzing certificates, physical-chemical testing, and adhering to strict hygiene standards. How to proceed step by step to ensure raw materials meet the requirements of pharmaceutical regulations and internal quality standards?

1. Certification and Compliance with Regulatory Requirements

The quality of pharmaceutical raw materials begins with clear regulatory requirements. In the European Union, all raw materials for drug production must comply with REACH and CLP regulations, which ensure the safety and proper labeling of chemical substances. The supplier should provide documentation confirming the registration of the raw material under REACH and its classification into the relevant category according to CLP/GHS. Certificates such as GMP (Good Manufacturing Practice) or GDP (Good Distribution Practice) are also important, as they demonstrate that the raw materials were manufactured and distributed in accordance with pharmaceutical standards.

Drug manufacturers should also request analytical certificates (CoA – Certificate of Analysis) from the supplier, which contain test results for purity, active ingredient content, and any impurities. These certificates should be issued by accredited laboratories and include analysis methods, specification limits, and actual measured values. Without these documents, it is impossible to guarantee that the raw material meets pharmacopoeia requirements (e.g., the European Pharmacopoeia) and is suitable for pharmaceutical use.

2. Analytical Methods for Verifying Raw Material Purity

Verifying the purity of pharmaceutical raw materials requires the use of standard analytical methods. The most common include chromatographic techniques such as HPLC (high-performance liquid chromatography) or GC (gas chromatography), which allow the detection of even trace amounts of impurities. Spectroscopic methods, such as infrared spectroscopy (IR) or nuclear magnetic resonance (NMR), are used to identify structure and confirm the identity of the substance. Karl Fischer titration is often used to determine water content.

Testing for microbiological purity is also crucial, especially for raw materials intended for parenteral or ophthalmic preparations. Standard test methods verify the absence of pathogenic microorganisms such as bacteria, fungi, or endotoxins. Manufacturers should have their own laboratory or collaborate with accredited laboratories that perform these analyses in accordance with current standards and pharmacopoeial requirements.

Photo: Ricardo Gomez Angel / Unsplash

3. Supplier evaluation and supply chain stability

Selecting a reliable supplier is crucial for ensuring consistent raw material quality. When evaluating a supplier, it is necessary to assess their industry experience, reference customers, and ability to deliver raw materials in the required quantity and quality. Transparency is also an important criterion – the supplier should allow audits of their production and storage facilities to verify compliance with GMP and other standards.

Supply chain stability is another critical factor. Pharmaceutical manufacturers should have backup suppliers for key raw materials to minimize the risk of supply disruptions. It is also important to monitor the origin of raw materials – for example, in the case of plant extracts, it must be verified whether they are cultivated and processed in accordance with quality and safety requirements. The supplier should provide complete documentation on the origin of the raw material and its processing.

4. Practical Steps for Quality Control Upon Raw Material Receipt

Upon receipt of pharmaceutical raw materials, it is essential to conduct an incoming inspection, which includes visual inspection of packaging, verification of labeling, and comparison of delivery documents with the order. Each batch should be assigned a unique identification number to ensure its traceability throughout the entire production process. It is also necessary to check whether the packaging is undamaged or uncontaminated and whether the raw materials are stored under the correct conditions (temperature, humidity, light).

After physical inspection, samples are taken for laboratory analysis. Samples should be collected according to standard procedures to ensure they are representative of the entire batch. The analysis results must be compared with the supplier's certificate and internal specifications. If deviations are detected, the raw material must be rejected or additional tests conducted. Regular quality control of raw materials helps prevent production errors and ensures the safety and efficacy of the final medicinal products.

Photo: American Public Power Association / Unsplash

Importance of validating the supplier's manufacturing processes

The quality of pharmaceutical raw materials begins with the supplier's manufacturing process. Validation of these processes is crucial to ensure consistent purity and efficacy of substances. Drug manufacturers should require documentation confirming that the supplier regularly verifies their manufacturing procedures in accordance with Good Manufacturing Practice (GMP) standards. This includes monitoring critical parameters such as temperature, pressure, reaction time, or the purity of input raw materials. Validation should cover all stages of production, from synthesis to final processing and packaging.

Another important aspect is the traceability of production batches. The supplier should have a system in place that allows tracing the origin of each raw material batch back to the individual input materials. This is essential for the rapid identification and resolution of any quality issues. Drug manufacturers should prefer suppliers who conduct regular audits of their processes and can demonstrate long-term stability in the quality of their products.

The Role of Stabilizing Additives and Their Impact on Raw Material Quality

Many pharmaceutical raw materials are sensitive to environmental factors such as moisture, light, or oxygen, which can lead to degradation or loss of efficacy. Stabilizing additives, such as antioxidants, chelating agents, or buffering substances, play a key role in protecting these raw materials during storage and transport. Their selection and concentration must be carefully optimized to avoid undesirable interactions with the active ingredient or other components of the drug.

When evaluating the quality of raw materials, it is important to verify whether the supplier uses stabilising additives in accordance with regulatory requirements and whether their effects are sufficiently documented. This includes testing the stability of raw materials under various conditions, such as elevated temperature or humidity, according to standard test methods. Pharmaceutical manufacturers should also consider whether the additives affect the pharmacokinetic properties of the drug or its safety for patients.

Documentation and Data Management: How to Ensure Transparency and Audit Trail

Complete and accurate documentation is the foundation for verifying the quality of pharmaceutical raw materials. The supplier should provide detailed raw material specifications, including analytical certificates (CoA), which confirm their purity, identity, and other key parameters. These documents must be easily accessible and updated for each delivered batch. Pharmaceutical manufacturers should also request access to historical data to track long-term trends in raw material quality.

Modern data management systems, such as electronic laboratory notebooks (ELN) or quality management systems (QMS), can significantly facilitate the tracking and analysis of this information. It is important that the documentation includes not only test results but also details of the methods used, equipment, and personnel qualifications. This ensures that all data are reproducible and auditable, which is essential for meeting regulatory authority requirements.

Do You Need Reliable Pharmaceutical Raw Materials?

At GCG Group, we prioritize transparency and quality – every pharmaceutical raw material is supplied with complete technical documentation and safety data sheets (SDS) in compliance with current legislation. Our experts will advise you on selecting the right specifications and optimizing processes to minimize risks and ensure stable production. Contact us – or browse our catalog of over 1,300 products right away.